Vaccine vs. Moderna cancer increases remission in patients with melanomas – El Financiero
Adding a personalized cancer vaccine to the drug Keytruda kept in remission to more melanoma patients than immune therapy alone, they reported Sunday Moderna y Merck & Cowhich revealed the details of a key study. About 79 percent of people who received both treatments remained cancer-free 18 months later in a mid-stage trial, compared with … Read more